Eversheds advises BOCI Asia in connection with Consun Pharmaceutical IPO
The Hong Kong office of Eversheds has advised BOCI Asia in connection with the HKD1.09bn (£86m) initial public offering (IPO) of Consun Pharmaceutical Group in Hong Kong. Consun Pharmaceutical Group — which was successfully listed on 19 December 2013 — is an integrated pharmaceutical company principally engaged in the research, manufacturing and sale of modern Chinese […]